The London COPD Exacerbation Cohort (EXCEL_Cohort)

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Other

Identifiers

NCT02755974
14IC1925

Details and patient eligibility

About

The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.

Full description

Our intentions are to phenotype Chronic Obstructive Pulmonary Disease (COPD) patients on the basis of factors that a related to (a) exacerbation frequency which will include (b) lung function to assess disease severity, (c) baseline therapy, (d) airway and systemic inflammatory markers, (e) health status, (f) gene expression, (g) airway bacterial and viral load and (h) co-morbidity including cardiovascular disease, diabetes and psychological disease, (i) psychological factors,(j) mortality, (k) nasal susceptibility to rhinovirus infection, (l) heart rate variability (m) exhaled hydrogen sulphide.

Enrollment

300 estimated patients

Sex

All

Ages

40 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

* Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of \<0.70 * Able and willing to give informed and written consent

Exclusion criteria

* Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded. * Patients on Immunosuppressive medications or with active cancer * Long term steroid therapy * Age \<40 years at recruitment

Trial contacts and locations

1

Loading...

Central trial contact

Gavin C Donaldson, PhD; Jadwiga A Wedzicha, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems